Elan

Kelly Martin skips to a new CEO suite as his last biotech team raises the white flag
Endpoints
Thu, 04/30/20 - 10:36 am
Kelly Martin
Pharma CEOs
Elan
Radius Health
Ex-Elan execs target €325M IPO for life science fund
Fierce Biotech
Tue, 03/3/15 - 09:46 am
Elan
IPOs
Malin
Kelly Martin
Top 10 Pharma M&A deals of 2013
Fierce Pharma
Thu, 04/17/14 - 08:29 am
M&A
Amgen
ONYX Pharmaceuticals
Bausch & Lomb
Valeant Pharmaceuticals
Elan
Perrigo
Actavis
Warner Chilcott
Bristol-Myers Squibb
AstraZeneca
Pearl Therapeutics
Agila
Mylan
Salix
Santarus
Bayer
Algeta
Shire
ViroPharma
Buzz: If it's an Irish biopharma company, it's on analysts' M&A list
Fierce Biotech
Fri, 01/3/14 - 12:52 pm
Ireland
M&A
Elan
Warner Chilcott
Gentium
Jazz Pharmaceuticals
Alzheimer's Disease Could Become the Next Frontier in Pharmaceutical Research
Motley Fool
Tue, 11/19/13 - 07:40 am
Alzheimer's disease
R&D
JNJ
Eli Lilly
Pfizer
Elan
General Electric
Vizamyl
Amyvid
bapineuzumab
solanezumab
SAC, Prosecutors Oppose Wyeth-Elan Investor Request
Bloomberg
Sat, 11/9/13 - 12:41 pm
Elan
legal
Elan Investors Ask SAC Capital Judge Insist on Admission
Bloomberg
Sat, 11/2/13 - 11:38 am
Elan
3 Signs We Could Be Entering a Biotech Bubble
Motley Fool
Sat, 09/28/13 - 01:09 pm
biotech
Perrigo
Bristol-Myers Squibb
Elan
Clovis Oncology
IPOs
Stemline
Amgen
Biogen Idec
ONYX Pharmaceuticals
'Doctor-2' in Elan, Wyeth insider trading case said to be well connected Alzheimer's doc
Fierce Pharma
Fri, 09/6/13 - 10:44 am
Elan
insider trading
Wyeth
physicians
Alzheimer's disease
Understanding the Massive Market Potential of Monoclonal Antibodies
Motley Fool
Wed, 08/28/13 - 04:53 pm
monoclonal antibodies
Roche
Herceptin
Rituxan
Avastin
GSK
Amgen
Eli Lilly
Bristol-Myers Squibb
Seattle Genetics
Adcetris
Kadcyla
bapineuzumab
Elan
JNJ
Pfizer
necitumumab
AbbVie
Humira
The Past, Present, and Future of Alzheimer’s Treatments
Motley Fool
Fri, 08/23/13 - 09:26 am
Alzheimer's disease
Aricept
Pfizer
Eisai
Actavis
Namenda
Eli Lilly
Forest Labs
bapineuzumab
JNJ
Elan
Perrigo Company
solanezumab
PBT2
Prana Biotechnology
[video] Perrigo's $8.6B Elan Deal Could Save $150M in Taxes
Bloomberg
Mon, 07/29/13 - 12:01 pm
Perrigo
Elan
Game may not be over for Royalty' Pharma's bid for Elan
Reuters
Thu, 06/27/13 - 08:59 pm
M&A
Elan
Royalty Pharma
Mylan
Allergan
Endo Health Solutions
Forest Labs
Forest Laboratories one of several suitors for Elan, report says
Marketwatch
Wed, 06/19/13 - 03:46 pm
Elan
Forest Labs
M&A
Royalty Pharma lets takeover bid for drugmaker Elan expire, decides against court challenge
Yahoo/AP
Tue, 06/18/13 - 11:42 am
Elan
M&A
Royalty Pharma
Elan Shareholder Vote Nixes Royalty Pharma Takeover -- For Now
TheStreet.com
Mon, 06/17/13 - 09:47 am
Elan
M&A
Royalty Pharma
J&J Says It Sells Final Stake in Elan for $332 Million
Bloomberg
Sat, 06/15/13 - 01:09 pm
JNJ
Elan
Elan Is In Play
Seeking Alpha
Sat, 06/15/13 - 01:01 pm
Elan
M&A
Elan Inviting Royalty Pharma Bid Shows Hostility Easing
Bloomberg
Sat, 06/15/13 - 01:01 pm
Elan
Royalty Pharma
M&A
J&J Says It Sells Final Stake in Elan for $332 Million
Bloomberg
Fri, 06/14/13 - 08:08 am
bapineuzumab
Elan
JNJ

Pages